Abstract:Abstract The androgen receptor (AR) transcription factor plays a key role in the development and progression of prostate cancer. Inhibition of its ligand by androgen deprivation therapy (ADT) is consequently the main medical treatment of invasive prostate cancer. AR is activated and maintained throughout prostate cancer progression even in castration resistant prostate cancer (CRPC). Prostate cancer cells escape from ADT using a variety of mechanisms. The AR and target genes have therefore become even more focused therapeutic targets in aggressive and disseminated prostate cancer. AR and its classical target genes, such as KLK3 (PSA) are, however, efficiently shut off in basal epithelial prostate cells and possibly in prostate cancer stem cells (CSCs). To investigate mechanisms of AR and AR target gene activation in different subpopulations of prostate cancer cells, several androgen response elements (ARE) reporter vectors were developed. Three ARE reporter vectors were constructed with different ARE consensus sequences in promoters linked to either fluorescence or luciferase reporter genes in lentiviral vector backbones. Cell lines transduced with the different vectors expressed the reporters in an androgen-dependent way according to fluorescence microscopy, flow cytometry and multi-well fluorescent and luminescence recording. The 241B promoter sequence reporter was selected among the constructed ARE reporters on the basis of higher activity in initial screenings. The AR positive and androgen responsive prostate cancer cell line, LNCaP, and the prostate transit amplifying epithelial cell line, EP156T-AR with exogenous AR, were transduced with the lentiviral 241B-mCherry fluorescence reporter. Flow cytometry, multi-well reader and fluorescence microscopy results corresponded when reporter cells were treated with androgen and with the AR antagonist, enzalutamide, and with the anti-androgen, abiraterone. An SV40-promoter GFP reporter element was next cloned into the 241B-mCherry reporter. Constitutive expression of GFP facilitated normalization of ARE driven mCherry fluorescent signals. Furthermore, AR expression vectors were also constructed with the AR open reading frames cloned into lentiviral expression vectors and used in co-transfection and co-transduction experiments in AR negative cell types. The developed ARE reporter system will help us to investigate the role of the AR in differentiation and proliferation of prostate cells and to study the AR activity in two and three dimensional cell cultures. This system can also be useful in screening for drugs with activity against the AR. Citation Format: Waqas Azeem, Margrete R. Hellem, Jan R. Olsen, Yaping Hua, Kristo Marvyin, Lisha Li, Yi Qu, Biaoyang Lin, Xisong Ke, Anne M. Oyan, Karl-Henning Kalland. Assays for androgen receptor activity using cell based ARE reporter systems. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 2902.

Expression and transcription of androgen receptor in prostate cancer cell lines with different characteristics of androgen independence

Expression of Androgen Receptor in Breast Cancer and Its Prognostic Significance

Changes of Androgen Receptor Expression in Hormonal Dependent Prostatic Cancer and Hormonal Independent Prostatic Cancer

Expressions of the Androgen Receptor in Normal Prostate, Benign Prostatic Hyperplasia and Prostate Cancer

[Expression and regulation of androgen receptor in the androgen-independent conversion of prostate cancer cells].

Androgen Receptor Isoforms in Human Prostatic Cancer Tissue and LNCaP Cell Line.

Expression of lncRNA PCGEM1 and AR co-localization in prostate cancer and tis signiifcance

Androgen Receptor Up-Regulates EphA3 Expression in Androgen-Dependent Prostate Cancer Cell Lines

Abstract 1824: Context Dependent Regulatory Patterns of the Androgen Receptor (AR) and Androgen Receptor Target Genes

An Androgen Response Element Driven Reporter Assay for the Detection of Androgen Receptor Activity in Prostate Cells

Transactivity Alterations of Androgen Receptor Mutants in PC-3 Cells of Advanced Prostate Cancers

Abstract 2902: Assays for Androgen Receptor Activity Using Cell Based ARE Reporter Systems

Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer

Role of Androgen Receptor in the Pathogenesis of Human Prostate Cancer

The Diverse and Contrasting Effects of Using Human Prostate Cancer Cell Lines to Study Androgen Receptor Roles in Prostate Cancer

Androgen Receptor Level Controlled by a Suppressor Complex Lost in an Androgen-Independent Prostate Cancer Cell Line.

Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells

Differential expression and function of AR isoforms in prostate cancer.

Linking Prostate Cancer Cell AR Heterogeneity to Distinct Castration and Enzalutamide Responses

Characterization of the androgen receptor in a benign prostate tissue-derived human prostate epithelial cell line: RC-165N/human telomerase reverse transcriptase

Comprehensive analysis of androgen receptor status in prostate cancer with neuroendocrine differentiation